Related Experiment Video
Updated: Jun 25, 2026

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
Published on: March 16, 2022
Translation initiation of the human tau mRNA through an internal ribosomal entry site
1Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA.
Abstract:
Neurofibrillary tangles are a pathological phenotype in Alzheimer's disease (AD) and are caused by the hyperphosphorylation of the microtubule associated protein tau. In mouse models of AD, decreasing tau protein expression limits the severity of symptoms and inhibits progression of AD. We now report that the 5' leader in the human tau mRNA contains an internal ribosomal entry site (IRES) and that IRES-dependent translation plays a role in the synthesis of tau protein. Consequently, targeting the tau IRES provides a novel target for regulating tau expression in AD and other tauopathies.
Insights
Researchers discovered an internal ribosomal entry site (IRES) in human tau mRNA, suggesting a new way to control tau protein levels. Targeting this tau IRES could offer a novel therapeutic strategy for Alzheimer's disease (AD) and other tauopathies.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neurofibrillary tangles, a hallmark of Alzheimer's disease (AD), result from tau protein hyperphosphorylation.
- Reducing tau protein levels in mouse models of AD alleviates disease severity and progression.
Purpose of the Study:
- To investigate the role of internal ribosomal entry sites (IRES) in the translation of human tau mRNA.
- To identify novel therapeutic targets for regulating tau expression in AD and related tauopathies.
Main Methods:
- Analysis of the 5' leader sequence of human tau mRNA.
- Experimental validation of IRES-dependent translation of tau protein.
Main Results:
- The 5' leader of human tau mRNA possesses an internal ribosomal entry site (IRES).
- IRES-dependent translation significantly contributes to tau protein synthesis.
Conclusions:
- Tau IRES-dependent translation is a key mechanism in tau protein production.
- Targeting the tau IRES presents a novel therapeutic strategy for Alzheimer's disease and other tauopathies.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
Cotranslational Protein Translocation
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Improving Translational Accuracy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

